Compounded Pain Preparation Absorption Study

NCT02205229 · Status: SUSPENDED · Type: OBSERVATIONAL · Enrollment: 40

Last updated 2015-05-18

No results posted yet for this study

Summary

Single center, prospective, observational study to assess serum concentration of ingredients used in multi-ingredient, topical compounded medications from Medimix Specialty Pharmacy.

Conditions

Interventions

DRUG

Multi-ingredient, topical compounded medications

Sponsors & Collaborators

  • Medimix Specialty Pharmacy, LLC

    lead INDUSTRY

Eligibility

Min Age
30 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-08-31
Primary Completion
2015-08-31
Completion
2015-08-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02205229 on ClinicalTrials.gov